Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;39(13-14):487-493.
doi: 10.1177/08830738241282354. Epub 2024 Sep 23.

Cerebral Cortical Encephalitis and Other Meningocortical Manifestations of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in Children: Case Series and Review of the Literature

Affiliations
Review

Cerebral Cortical Encephalitis and Other Meningocortical Manifestations of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in Children: Case Series and Review of the Literature

Richard B Carozza et al. J Child Neurol. 2024 Nov.

Abstract

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease is a neuroinflammatory disorder (MOGAD) with heterogeneous phenotype including paroxysms of optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, brainstem demyelination, and encephalitis. Fluid-attenuated inversion recovery hyperintense cortical lesions in MOG-associated encephalitis with seizures, or FLAMES, is a manifestation of cerebral cortical encephalitis seen less frequently than other typical MOG antibody-associated disease presentations. Cases of FLAMES are rarer in children, and frequently initially misdiagnosed with infectious meningoencephalitis. Other meningocortical manifestations of MOG antibody-associated disease have been described and likely exist along a continuum. In this retrospective single-center case series, we describe the demographic, clinical, radiographic, laboratory, and electroencephalographic features of 5 children with clinicoradiographic features consistent with the spectrum of MOG-IgG-positive meningocortical syndromes.

Keywords: cortical cerebral encephalitis (CCE); demyelinating; myelin oligodendrocyte glycoprotein (MOG); myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD); seizure.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Brain magnetic resonance imaging (MRI) of patients with MOG-IgG–positive meningocortical syndromes. Patient 1: Axial T2-weighted fluid-attenuated inversion recovery (T2-FLAIR) image post-gadolinium (A) during initial presentation demonstrates cortical hyperintensity of the left temporal, parietal, and occipital lobes with associated leptomeningeal enhancement as well as juxtacortical hypointensity. Axial T2-weighted fluid-attenuated inversion recovery image post-gadolinium (B) during relapse demonstrates right frontoparietal leptomeningeal enhancement. Axial arterial spin labeling (ASL) image (C) demonstrates corresponding area of localized hyperperfusion. Patient 2: Axial T2-weighted fluid-attenuated inversion recovery image pre-gadolinium demonstrates bilateral frontal lobe hyperintensity and juxtacortical hypointensity (D), and axial T1 image post-gadolinium demonstrates right frontal leptomeningeal enhancement (E). Patient 3: Axial T2-weighted fluid-attenuated inversion recovery image post-gadolinium (F) demonstrates right superior frontal leptomeningeal enhancement. Patient 4: Axial diffusion-weighted imaging (DWI) image (G) demonstrates right frontoparietal restricted diffusion with corresponding apparent diffusion coefficient (ADC) image (H). Patient 5: Axial T2 pre-gadolinium images (I, J) demonstrate left frontal hyperintensity of the cortex with juxtacortical hyperintensity. Axial T1 post-gadolinium images (K, L) demonstrate left frontal leptomeningeal and subcortical enhancement. Axial ASL image (M) demonstrates possible area of corresponding localized hyperperfusion.

References

    1. Cobo-Calvo A, Ruiz A, Rollot F, et al. Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol. 2021;89(1):30‐41. - PubMed
    1. Banwell B, Bennett JL, Marignier R, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268‐282. - PubMed
    1. Ogawa R, Nakashima I, Takahashi T, et al. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neuro Neuroimmunol Neuroinflamm. 2017;4(2):e322. - PMC - PubMed
    1. Budhram A, Mirian A, Sharma M. Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: review of a novel clinico-radiographic spectrum. Front Neurol. 2022;13:1044642. - PMC - PubMed
    1. Budhram A, Kunchok A, Flanagan E. Adding FUEL to the FLAMES: FLAIR-variable Unilateral Enhancement of the Leptomeninges (FUEL) in MOG-IgG Associated Disease. NEurology. 2020;94(15).